Dr. Jekyll and Mr. Hyde: Pharmaceutical Companies Contend with Drug Benefit and Risk Communications

February 20, 2006

About the Author **photo-1**Edward Morawski is a leading expert in pharmaceutical brand equity and brand management research. Ed helps pharmaceutical clients identify fact-based and insightful answers to major marketing challenges. Ed's focus on global research in the pharmaceutical sector has helped to grow Ipsos Health into a trusted provider of quality research and industry leader. In addition to managing project teams on global and domestic physician research, Ed continues to build Ipsos Health's knowledge base on physician and patient opinion to maintain the practice's high-level understanding of the pharmaceutical market. Ed began his career in the … Subscribe Now Purchase Article for $40.00 Registered User Log In Email Address Password Login Forgot your username or password? UPCOMING CONFERENCES HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone June 27, 2024 - Buffalo, NY The Richardson Hotel Buffalo MORE DETAILS HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates May 29, 2024 - Salt Lake City, UT The Grand America Hotel MORE DETAILS Sign Up For Email Alerts × Email address Publications Asbestos Benzene & Emerging Toxic Torts Litigation Camp Lejeune & Water Contamination Drugs & Medical Devices MDL Mass Tort & Class Action Monitor Reinsurance & Arbitration Talcum Powder Litigation Report Close Submit